Venus Concept Inc. to Participate in Two Upcoming Investor Conferences on March 17th
03/11/2021 - 04:05 PM
TORONTO, March 11, 2021 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, today announced that management will participate in the following upcoming investor conferences in March:
The Oppenheimer 31 st Annual Healthcare Conference, which is being held virtually from March 16 th -18 th .
Management will present on Wednesday, March 17th at 3:10 p.m. Eastern Time. The Maxim Emerging Growth Conference, which is being held virtually from March 17 th -18 th .
Management’s presentation will be available on-demand beginning on Wednesday, March 17th . The Company will also participate in a panel discussion session titled “Maxim Group’s Virtual Aesthetic Panel” on Wednesday, March 17th at 2:00pm Eastern time. To access the conference presentations and panel discussions, please register using the conference link here . Audio webcasts of the presentations will be accessible under the “Events” section of the Company's investor relations website at https://ir.venusconcept.com/ .
About Venus Concept
Venus Concept is an innovative global medical aesthetic technology leader with a broad product portfolio of minimally invasive and non-invasive medical aesthetic and hair restoration technologies and reach in over 60 countries and 20 direct markets. Venus Concept focuses its product sales strategy on a subscription-based business model in North America and in its well-established direct global markets. Venus Concept’s product portfolio consists of aesthetic device platforms, including Venus Versa, Venus Legacy, Venus Velocity, Venus Fiore, Venus Viva, Venus Freeze Plus, Venus Heal, Venus Glow, Venus Bliss, Venus Epileve and Venus Viva MD. Venus Concept’s hair restoration systems includes NeoGraft®, an automated hair restoration system that facilitates the harvesting of follicles during a FUE process and the ARTAS® and ARTAS iX® Robotic Hair Restoration systems, which harvest follicular units directly from the scalp and create recipient implant sites using proprietary algorithms. Venus Concept has been backed by leading healthcare industry growth equity investors including EW Healthcare Partners (formerly Essex Woodlands), HealthQuest Capital, Longitude Capital Management, and Aperture Venture Partners.
VERO Rankings
#4034 Ranked by Stock Gains
VERO Stock Data
Industry
Surgical Appliance and Supplies Manufacturing
Sector
Manufacturing
Tags
Health Technology, Medical Specialties, Manufacturing, Surgical Appliance and Supplies Manufacturing
Country
Canada
City
Toronto
About VERO
venus concept is a leader in the global medical aesthetic market, pairing best-in-class technology with the first and only true subscription model in the industry. our goal is to help both new and established practices succeed in this growing field. we understand the challenges of breaking into and being successful in the aesthetics industry, and that’s why we’re changing the game with an innovative solution. the secret is in our industry-unique subscription model. in partnering with venus concept, aesthetic professionals worldwide gain access to never-before-seen business features such as the most comprehensive warranty program, unmatched marketing support, continuous clinical education, valuable practice enhancement programs, and more. together with this business model, our collection of aesthetic systems—including venus versa™, venus legacy™, venus velocity™, venus viva™, venus freeze plus™, and venus skin™—are setting higher industry standards and improving the quality of life for
